BSE Corporate News   

@BSE_News

AARTIDRUGS - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate

28/11/2022 03:24:04 PM     Share:    

---

  BSE Corporate News   

@BSE_News

AARTIDRUGS - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate

24/11/2022 09:29:05 PM     Share:    

---

  BSE Corporate News   

@BSE_News

AARTIDRUGS - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome

31/10/2022 07:20:04 PM     Share:    

---

  #ALKESH   

@alkeshthakkar

#AARTIDRUGS #APCOTEXIND #BAJAJFINSV #BSOFT #birlasoft

27/10/2022 11:24:00 PM     Share:    

---

  CNBC-TV18   

@CNBCTV18News

#2QWithCNBCTV18 | Aarti Drugs reported a mixed set of Q2 nos. September quarter saw maximum realisations in API+chemicals segments, says CFO Adhish Patil. Tells @_soniashenoy @SumairaAbidi & @PavitraParekh1 that he expects gross contribution to increase going ahead @ekta_batra

27/10/2022 12:00:39 PM     Share:    

---

  CNBC-TV18   

@CNBCTV18Live

#OnCNBCTV18 | Coal & power costs remained high in Q2FY23. Export demand has been good. 15% composite growth is achievable in FY23, says Adhish Patil of Aarti Drugs

27/10/2022 11:27:16 AM     Share:    

---

  #ALKESH   

@alkeshthakkar

#AARTIDRUGS #AMBUJACEM #CLEAN

23/10/2022 02:17:01 AM     Share:    

---

  EquityBulls.com   

@equitybulls

Aarti Drugs Ltd posts consolidated PAT of Rs. 38.75 crores in Q2FY23 #AartiDrugs #Q2FY23 #H1FY23 #ResultUpdate

20/10/2022 09:02:11 PM     Share:    

---

  #ALKESH   

@alkeshthakkar

#AARTIDRUGS AARTI DRUGS RESULT

20/10/2022 08:29:00 PM     Share:    

---

  Nirmal Bang   

@NirmalBang

Aarti Drugs Ltd.: Result is ok #ResultUpdate #nse #bse #nirmalbang #Q2FY2023 #quarterlyresults #StockMarket #StockMarketindia #Pharmaceuticals #AartiDrugs

20/10/2022 05:02:00 PM     Share:    

---

  CNBC-TV18   

@CNBCTV18Live

Aarti Drugs Q2 | #2QWithCNBCTV18 Cons net profit at Rs 38.75 cr Vs Rs 42.59 cr (YoY) Cons revenue at Rs 690 cr Vs Rs 580 cr (YoY)

20/10/2022 04:05:18 PM     Share:    

---

  ASHISH SHAH   

@Ashish_shah72

AARTI DRUGS LTD:Q2 CONS NET PROFIT 387M RUPEES VS 426M(YOY);348M(QOQ)||Q2 REVENUE 6.87B RUPEES VS 5.79B(YOY);6.21B(QOQ)

20/10/2022 03:44:50 PM     Share:    

---

  Markets Today   

@marketsday

#Results on October 20 ITC, Asian Paints, Axis Bank, Bajaj Finance, Tata Consumer Products, Colgate Palmolive, Aarti Drugs, Canara Bank, Central Bank of India, Clean Science and Technology, Coforge, Dixon Technologies, Happiest Minds Technologies, ICRA, Indian Energy Exchange,

20/10/2022 07:02:35 AM     Share:    

---

  Ashish Verma   

@AshVerma111

RESULTS #Tomorrow #KuchCashWaali AARTI DRUGS AAVAS CENTRAL BANK CLEAN SCIENCE DHAMPUR SUGAR EMBASSY OFFICE REIT ERIS LIFE GIPCL HAPPIEST MIND ICRA IIFL SEC ICICI SEC JUBILANT INGREVIA KEI MASTEK NAZARA NELCO SYMPHONY TANLA UNION BANK UTI AMC ZENSAR @CNBC_Awaaz

19/10/2022 10:53:41 AM     Share:    

---

  BSE Corporate News   

@BSE_News

AARTIDRUGS - Statement Of Investor Complaints For The Quarter Ended September 2022

10/10/2022 06:40:05 PM     Share:    

---

  Harneet Singh Kharbanda   

@TraderHarneet

Aarti Drugs.. Monthly chart with 50 Exponential Moving Average. What does this chart say ?

06/10/2022 05:06:03 PM     Share:    

---

  BSE Corporate News   

@BSE_News

AARTIDRUGS - Announcement under Regulation 30 (LODR)-Newspaper Publication

29/09/2022 06:52:09 PM     Share:    

---

  BSE Corporate News   

@BSE_News

AARTIDRUGS - Shareholder Meeting / Postal Ballot-Notice of Postal Ballot

28/09/2022 07:39:05 PM     Share:    

---

  CNBC-TV18   

@CNBCTV18Live

#JustIn | Aarti Drugs re-appoints Rashesh C. Gogri as Managing Director for 5 years w.e.f October 31

26/09/2022 08:56:56 PM     Share:    

---

  BSE Corporate News   

@BSE_News

AARTIDRUGS - Re-Appointment Of Managing Director/ Outcome Of Board Meeting

26/09/2022 08:50:04 PM     Share:    

---